Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0026986 (
myelodysplastic syndrome
)
14,926
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Some studies show that alterations in expression of proteins related to mitotic spindle (AURORAS KINASE A and B) and mitotic checkpoint (CDC20 and
MAD2L1
) are involved in chromosomal instability and tumor progression in various solid and hematologic malignancies. This study aimed to evaluate these genes in
MDS
patients. The cytogenetics analysis was carried out by G-banding, AURKA and AURKB amplification was performed using FISH, and AURKA, AURKB, CDC20 and
MAD2L1
gene expression was performed by qRT-PCR in 61 samples of bone marrow from
MDS
patients. AURKA gene amplification was observed in 10% of the cases, which also showed higher expression levels than the control group (p=0.038). Patients with normo/hypercellular BM presented significantly higher expression levels than hypocellular BM patients, but normo and hypercellular BM groups did not differ. After logistic regression analysis, our results showed that HIGH expression levels were associated with increased risk of developing normo/hypercellular
MDS
. It also indicated that age is associated with AURKA, CDC20 and
MAD2L1
HIGH expression levels. The distinct expression of hypocellular patients emphasizes the prognostic importance of cellularity to
MDS
. The amplification/high expression of AURKA suggests that the increased expression of this gene may be related to the pathogenesis of disease.
...
PMID:Proteins related to the spindle and checkpoint mitotic emphasize the different pathogenesis of hypoplastic MDS. 2431 88